Syros Pharmaceuticals Profit Margin

As of the most recent data (September 2024), SYRS shows a profit margin of -23683.68%. That compares with -1092.65% in the prior-year period — down 2067.5% year over year. That is below the Healthcare sector average of 9.48%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SYRS's profit margin is now -23683.68% (was -1092.65%) — a 2067.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Syros Pharmaceuticals is outperforming or lagging.

The Healthcare sector average profit margin is about 9.48%. Syros Pharmaceuticals is at -23683.68%, which is lower that average. That is roughly 249902.5% below the sector mean. Use the comparison chart on this page to see how SYRS stacks up against individual peers as well.

That compares with -1092.65% in the prior-year period — down 2067.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Syros Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Syros Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -23683.68%) with ownership activity and broader fundamentals.